Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | HPGD | P15428 | 3/20 | 0.33 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2624984 | 0.87 | SLC6A3 (0.37) | MEN1KMT2ARAB9ANPC1ALDH1A1 | |
| SCHEMBL2624986 | 0.87 | SCN9A (0.32) | MEN1KMT2ARAB9ANPC1ALDH1A1 | |
| SCHEMBL10053050 | 0.86 | TP53 (0.42) | MEN1KMT2ARAB9ANPC1ALDH1A1 | |
| SCHEMBL2739900 | 0.80 | MEN1 (0.38) | MEN1KMT2ARAB9ANPC1ALDH1A1 | |
| SCHEMBL32688719 | 0.78 | MEN1 (0.41) | MEN1KMT2ARAB9ANPC1ALDH1A1 | |
| SCHEMBL13197281 | 0.78 | LMNA (0.46) | MEN1KMT2ARAB9ANPC1ALDH1A1 | |
| SCHEMBL2624983 | 0.78 | MAPT (0.40) | KMT2AALDH1A1MAPTLMNA | |
| SCHEMBL13197275 | 0.77 | MEN1 (0.35) | MEN1KMT2ARAB9ANPC1ALDH1A1 | |
| SCHEMBL2632587 | 0.74 | MEN1 (0.35) | MEN1KMT2ARAB9ANPC1 | |
| SCHEMBL31716524 | 0.74 | MEN1 (0.42) | MEN1KMT2ARAB9ANPC1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8158327-B2 | Onium salt compound, polymer compound comprising the salt compound, chemically amplified resist composition comprising the polymer compound, and method for patterning using the composition | KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) | 2012-04-17 | — | — | US | disclosed |
| US-20100075256-A1 | Onium salt compound, polymer compound comprising the salt compound, chemically amplified resist composition comprising the polymer compound, and method for patterning using the composition | KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) | 2010-03-25 | — | — | US | disclosed |
| US-7285373-B2 | Polymer and chemically amplified resist composition containing the same | KOREA KUMHO PETROCHEMICAL CO., LTD (KR) | 2007-10-23 | — | — | US | disclosed |
| US-7285373-B2 | Polymer and chemically amplified resist composition containing the same | KOREA KUMHO PETROCHEMICAL CO., LTD (KR) | 2007-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100075256-A1 | Onium salt compound, polymer compound comprising the salt compound, chemically amplified resist composition comprising the polymer compound, and method for patterning using the composition | ARF5, ARL1, FGFR2 | MEN1 3295/4885KMT2A 566/4885RAB9A 844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.